We are live on
!
Find out more
EOJOAM
E. Ohman J:or Asset Management Portfolio holdings
AUM
$4.3B
1-Year Est. Return
29.55%
This Fund
S&P 500
This Quarter
Est. Return
+12.32%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$2.55B
AUM Growth
+$262M
(+11%)
Cap. Flow
+$51.9M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
36.72%
Holding
441
New
20
Increased
150
Reduced
58
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$19M |
| 2 |
Natera
NTRA
|
+$18.8M |
| 3 |
NVIDIA
NVDA
|
+$17.3M |
| 4 |
UnitedHealth
UNH
|
+$16.1M |
| 5 |
Equinix
EQIX
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$36.7M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$16.3M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$14.3M |
| 4 |
Atkore
ATKR
|
+$12.2M |
| 5 |
MetLife
MET
|
+$5.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.13% |
| 2 | Healthcare | 16.41% |
| 3 | Financials | 15.3% |
| 4 | Consumer Discretionary | 11.38% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
BioCryst Pharmaceuticals
BCRX
$2.65B
| – | – |
-145,921
| Closed | -$1.68M |
|
427
CDW
CDW
$16.9B
| – | – |
-3,500
| Closed | -$625K |
|
428
CF Industries
CF
$17.8B
| – | – |
-5,500
| Closed | -$469K |
|
429
Cisco
CSCO
$475B
| – | – |
-71,000
| Closed | -$3.38M |
|
430
Cognizant
CTSH
$26.3B
| – | – |
-9,000
| Closed | -$515K |
|
|
DQ
431
Daqo New Energy
DQ
$995M
| – | – |
-9,000
| Closed | -$347K |
|
432
Dynatrace
DT
$14.4B
| – | – |
-5,200
| Closed | -$199K |
|
433
Loews
L
$23.2B
| – | – |
-9,300
| Closed | -$542K |
|
434
Lumen
LUMN
$6.61B
| – | – |
-41,400
| Closed | -$216K |
|
435
Ultragenyx Pharmaceutical
RARE
$2.63B
| – | – |
-85,000
| Closed | -$3.94M |
|
436
Roblox
RBLX
$26.4B
| – | – |
-15,600
| Closed | -$444K |
|
437
Western Union
WU
$2.2B
| – | – |
-18,300
| Closed | -$252K |
|
438
Zscaler
ZS
$28.8B
| – | – |
-1,500
| Closed | -$168K |
|
|
COUP
439
DELISTED
Coupa Software Incorporated
COUP
| – | – |
-205,885
| Closed | -$16.3M |
|
|
SIVB
440
DELISTED
SVB Financial Group
SIVB
| $0 | ﹤0.01% |
2,700
-50,827
| -95% | -$14.3M |
|
|
SBNY
441
DELISTED
Signature Bank
SBNY
| – | – |
-40,130
| Closed | -$4.62M |
|
Similar funds
IWM
CW
IUHSA
MYIA
NEI
CIC
SLI
E. Ohman J:or Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, E. Ohman J:or Asset Management held 441 positions worth $2.55B, up 11% from $2.29B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
E. Ohman J:or Asset Management's Q1 2023 filing shows 20 new, 150 increased, 58 reduced and 17 closed positions. Its largest new stake was Natera: 391,470 shares worth $21.7M. The largest sale was AbbVie, an estimated $36.7M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- E. Ohman J:or Asset Management's largest Q1 2023 buy was Natera: 391,470 shares worth $21.7M.
- E. Ohman J:or Asset Management added most to Edwards Lifesciences in Q1 2023, an estimated $19M increase.
- E. Ohman J:or Asset Management's biggest Q1 2023 reduction was SVB Financial Group, cutting an estimated $14.3M.
- E. Ohman J:or Asset Management fully exited AbbVie in Q1 2023, selling an estimated $36.7M.
- E. Ohman J:or Asset Management's ten largest holdings make up 37% of its $2.55B portfolio in Q1 2023.
- E. Ohman J:or Asset Management opened 20 new positions and closed 17 in Q1 2023.
- E. Ohman J:or Asset Management's portfolio value rose 11% quarter-over-quarter to $2.55B.
Based on E. Ohman J:or Asset Management's 13F filing for Q1 2023, filed 5 Apr 2024.